Trials / Terminated
TerminatedNCT02595814
Global Non-interventional Heart Failure Disease Registry
International Registry to Assess mEdical Practice With lOngitudinal obseRvation for Treatment of Heart Failure
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 18,805 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for acute HF.
Conditions
Timeline
- Start date
- 2014-07-23
- Primary completion
- 2018-03-31
- Completion
- 2018-03-31
- First posted
- 2015-11-03
- Last updated
- 2018-11-14
Locations
346 sites across 44 countries: United States, Algeria, Argentina, Australia, Austria, Brazil, Bulgaria, Canada, Chile, China, Colombia, Ecuador, Egypt, Germany, Greece, Guatemala, India, Indonesia, Israel, Japan, Jordan, Lebanon, Malaysia, Mexico, Morocco, Netherlands, Norway, Panama, Philippines, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey (Türkiye), United Arab Emirates, United Kingdom, Vietnam
Source: ClinicalTrials.gov record NCT02595814. Inclusion in this directory is not an endorsement.